Hester Biosciences

Hester Biosciences EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Hester Biosciences (HESTERBIO.NS) as of Nov 19, 2026 is 36.38. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 34.95 — a change of 4.10% (higher).

EV/FCF

36.38

YoY

4.10%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Hester Biosciences is 2026 36.38 . EV/FCF (Enterprise Value to Free Cash Flow) of Hester Biosciences was 2025 34.95 . It decreases by 4.10% higher compared to the previous year.

The Hester Biosciences EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
53.88 INR
Jan 1, 2020
-40.67 INR
Jan 1, 2021
81.87 INR
Jan 1, 2022
-17.63 INR
Jan 1, 2023
-29.12 INR
Jan 1, 2024
65.63 INR
Jan 1, 2025
34.95 INR
Jan 1, 2026
36.38 INR
The Hester Biosciences EV/FCF history
YEAREV/FCFYoY
36.38+4.10%
34.95-46.75%
65.63-325.34%
-29.12+65.24%
-17.63-121.53%
81.87-301.29%
-40.67-175.49%
53.88-41.42%
91.97-69.64%
302.95+21.96%
248.40-31.06%
360.33-240.60%
-256.28—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hester Biosciences Stock analysis

What does Hester Biosciences do? Hester Biosciences Ltd. generates revenue through its four operational segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The company sells poultry vaccines such as Gumboro I, Inactivated ND IB, and Live H120, alongside animal health products including Goat Pox Vaccine and PPR Vaccine - Nigerian 75/1. Petcare offerings like Cefshot Tazo Injection and Hestacef CV target veterinary clinics and pet owners. The firm serves agricultural businesses, veterinary practitioners, and pet care providers across India, with its products distributed through trade channels and direct sales to livestock farmers and clinics. Animal Healthcare segment focuses on livestock protection with vaccines for goats and cattle, while Poultry Healthcare provides specialized immunizations for commercial poultry farms. Diagnostic laboratory services complement the product portfolio, supporting livestock health management. The company's product range caters to both large-scale farming operations and smaller veterinary practices, ensuring consistent demand across its target markets. Revenue streams are derived from direct sales to farmers and veterinary clinics, as well as trade distribution networks. The firm's portfolio includes thermostable vaccines for poultry, such as Thermostable ND, which appeals to commercial poultry producers seeking reliable disease prevention solutions. Petcare products like Hestaflam Tablet are marketed to pet owners and veterinary hospitals, expanding the company's reach beyond traditional agricultural sectors. Hester Biosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hester Biosciences stock

EV/FCF (Enterprise Value to Free Cash Flow) of Hester Biosciences is 36.38 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Hester Biosciences changed from 34.95 to 36.38, representing a 4.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Hester Biosciences since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Hester Biosciences with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Hester Biosciences

All Key Metrics — Hester Biosciences